TD Asset Management
IGMS

TD Asset Management’s IGM Biosciences IGMS Stock Holding History

TD Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-164,472
Closed -$1M – 1238
2024
Q4 		$1M Hold
164,472
– – ﹤0.01% 1112
2024
Q3 		$2.8M Hold
164,472
– – ﹤0.01% 927
2024
Q2 		$1.13M Buy
164,472
+5,350
+3% +$45.8K ﹤0.01% 1143
2024
Q1 		$1.54M Buy
159,122
+75,670
+91% +$877K ﹤0.01% 1086
2023
Q4 		$693K Hold
83,452
– – ﹤0.01% 1251
2023
Q3 		$697K Buy
83,452
+41,726
+100% +$354K ﹤0.01% 1207
2023
Q2 		$385K Buy
41,726
+22,833
+121% +$256K ﹤0.01% 1303
2023
Q1 		$260K Sell
18,893
-13,666
-42% -$283K ﹤0.01% 1358
2022
Q4 		$554K Hold
32,559
– – ﹤0.01% 1271
2022
Q3 		$633K Hold
32,559
– – ﹤0.01% 1253
2022
Q2 		$587K Hold
32,559
– – ﹤0.01% 1266
2022
Q1 		$870K Sell
32,559
-17,472
-35% -$325K ﹤0.01% 1255
2021
Q4 		$1.47M Buy
50,031
+8,745
+21% +$435K ﹤0.01% 1203
2021
Q3 		$2.71M Buy
41,286
+5,500
+15% +$421K ﹤0.01% 997
2021
Q2 		$2.43M Sell
35,786
-2,622
-7% -$194K ﹤0.01% 1034
2021
Q1 		$2.95M Buy
38,408
+8,207
+27% +$747K ﹤0.01% 986
2020
Q4 		$2.67M Buy
30,201
+9,527
+46% +$670K ﹤0.01% 950
2020
Q3 		$1.53M Sell
20,674
-4,200
-17% -$249K ﹤0.01% 972
2020
Q2 		$1.82M Buy
24,874
+1,300
+6% +$79K ﹤0.01% 901
2020
Q1 		$1.32M Sell
23,574
-5,200
-18% -$228K ﹤0.01% 928
2019
Q4 		$1.1M Hold
28,774
– – ﹤0.01% 1070
2019
Q3 		$511K Buy
+28,774
New +$581K ﹤0.01% 1167

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

TD Asset Management's IGMS Position: Q1 2025 in Review

TD Asset Management sold out of IGM Biosciences (IGMS) in Q1 2025, closing a stake of 164,472 shares — an estimated $1M sold.

TD Asset Management first reported a position in IGMS in Q3 2019 and held it in 22 quarters. The position peaked at $2.95M in Q1 2021. 79 funds tracked by Wall St. Rank hold IGMS as of Q1 2025.

  • TD Asset Management reported no remaining IGM Biosciences position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 164,472 IGM Biosciences shares in Q1 2025, an estimated $1M.
  • TD Asset Management first reported a position in IGM Biosciences in Q3 2019 and held it in 22 quarters.
  • TD Asset Management's IGM Biosciences position peaked at $2.95M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.